Literature DB >> 15229470

Therapeutics targeting the innate immune system.

Richard J Ulevitch1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15229470     DOI: 10.1038/nri1396

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  62 in total

Review 1.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 2.  Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses.

Authors:  Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs).

Authors:  Chittoor P Swaminathan; Patrick H Brown; Abhijit Roychowdhury; Qian Wang; Rongjin Guan; Neal Silverman; William E Goldman; Geert-Jan Boons; Roy A Mariuzza
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

Review 4.  Role of Toll-like receptors in infection and immunity: clinical implications.

Authors:  Patricia Cristofaro; Steven M Opal
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma.

Authors:  Yashu Liu; Jintang He; Xaiolei Xie; Gang Su; Seagal Teitz-Tennenbaum; Michael S Sabel; David M Lubman
Journal:  J Proteome Res       Date:  2010-10-20       Impact factor: 4.466

6.  Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.

Authors:  Brian B Gowen; Donald F Smee; Min-Hui Wong; John W Judge; Kie-Hoon Jung; Kevin W Bailey; Anne M Pace; Barnett Rosenberg; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 7.  Liposome-nucleic acid immunotherapeutics.

Authors:  Steven Dow
Journal:  Expert Opin Drug Deliv       Date:  2008-01       Impact factor: 6.648

8.  [Focus on tumor immunology of transitional cell carcinoma].

Authors:  P J Olbert; A J Schrader; A Hegele; R Hofmann
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

9.  Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.

Authors:  Felix N Toka; Charles K Nfon; Harry Dawson; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

Review 10.  Targeting TLR/IL-1R signalling in human diseases.

Authors:  Maria Loiarro; Vito Ruggiero; Claudio Sette
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.